Takeda Pharmaceutical Ownership | Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical Ownership Summary

Takeda Pharmaceutical is owned by 3.10% institutional investors, 0.02% insiders, and 96.88% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.60% of TAK shares. American Funds American Mutual A is the top mutual fund, with 0.57% of its assets in Takeda Pharmaceutical shares.

TAK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Takeda Pharmaceutical	3.10%	0.02%	96.88%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.67%	13.90%	65.43%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Capital research global investors	19.10M	0.60%	$353.81M
Fmr	7.12M	0.23%	$131.82M
Morgan stanley	6.47M	0.20%	$119.82M
Adage capital partners gp	6.42M	0.20%	$118.99M
Goldman sachs group	5.62M	0.18%	$104.06M
Brandes investment partners, lp	4.43M	0.14%	$82.06M
Blackrock funding, inc. /de	3.18M	0.10%	$58.83M
Arrowstreet capital, limited partnership	3.12M	0.10%	$57.71M
Renaissance	2.99M	0.09%	$55.36M
Blackrock	1.44M	0.09%	$18.59M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Managed asset portfolios	1.80M	3.99%	$33.31M
Clean yield group	238.37K	1.24%	$4.41M
Legacy wealth asset management	165.80K	0.75%	$3.07M
Gold investment management	111.30K	0.64%	$2.06M
Brandes investment partners, lp	4.43M	0.58%	$82.06M
Carrera capital advisors	165.12K	0.47%	$3.06M
Arjuna capital	62.20K	0.29%	$1.15M
First affirmative financial network	41.85K	0.29%	$612.71K
Corient ia	14.88K	0.26%	$275.58K
Bayforest capital	10.29K	0.21%	$190.59K

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	6.42M	0.18%	6.42M
Capital research global investors	19.10M	0.05%	5.62M
Fmr	7.12M	0.01%	3.06M
Capital wealth planning	886.84K	0.09%	886.84K
Goldman sachs group	5.62M	0.01%	813.49K

Top Sellers

Holder	Shares	% Assets	Change
Arrowstreet capital, limited partnership	3.12M	0.03%	-2.57M
Millennium management	246.66K	0.00%	-1.75M
D. e. shaw	2.60M	0.03%	-1.69M
Ubs group	2.74M	0.01%	-1.38M
Soleus capital management	-	-	-1.18M

New Positions

Holder	Shares	% Assets	Change	Value
Adage capital partners gp	6.42M	0.18%	6.42M	$118.99M
Capital wealth planning	886.84K	0.09%	886.84K	$16.42M
Cowen and company	530.60K	0.19%	530.60K	$6.87M
Two sigma investments, lp	311.70K	0.00%	311.70K	$5.77M
Trexquant investment lp	229.46K	0.03%	229.46K	$4.25M

Sold Out

Holder	Change
Northwest financial advisors	-1.00
Rise advisors	-1.00
West branch capital	-3.00
Point72 asia (singapore) pte.	-3.00
Bogart wealth	-7.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	354	0.85%	97,837,706	16.83%	3	44.08%	223	38.51%	60	-52.76%
Dec 31, 2025	209	-37.61%	39,526,007	-53.64%	1	16.85%	82	-58.16%	84	12.00%
Sep 30, 2025	203	-33.88%	18,053,624	-72.33%	-	3.49%	110	-39.56%	45	-28.57%
Jun 30, 2025	309	-0.32%	77,823,025	9.47%	4	24.04%	185	9.47%	63	-29.21%
Mar 31, 2025	3	-98.99%	4,050,360	-94.38%	-	1.24%	2	-98.64%	1	-98.94%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds American Mutual A	18.16M	0.57%	5.27M
Capital Group American Mutual Comp	18.16M	0.57%	5.27M
First Trust Value Line® Dividend ETF	1.98M	0.06%	-1.74K
VanEck Pharmaceutical ETF	1.67M	0.05%	-
Capital Group American Mutual Trust U0	946.32K	0.03%	347.59K
Amplify CWP International Enh Div IncETF	947.00K	0.03%	-
MAP Global Equity Composite	902.12K	0.03%	167.32K
Mondrian Int Eq Delivered Strategy	816.00K	0.03%	-1.77M
Steward Values Enhanced International I	711.87K	0.02%	-
Steward International Enhanced Index I	651.53K	0.02%	315.75K

Insider Transactions Trends

Date	Buy	Sell
2028 Q2	-	-
2028 Q1	-	-
2026 Q1	-	-
2022 Q4	-	-

TAK Ownership FAQ

Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical shareholders are primarily institutional investors at 3.10%, followed by 0.02% insiders and 96.88% retail investors. The average institutional ownership in Takeda Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Takeda Pharmaceutical falls below.

Who owns the most shares of Takeda Pharmaceutical?

Takeda Pharmaceutical’s largest shareholders are Capital research global investors (19.1M shares, 0.60%), Fmr (7.12M shares, 0.23%), and Morgan stanley (6.47M shares, 0.20%). Together, they hold 1.03% of Takeda Pharmaceutical’s total shares outstanding.

Does Blackrock own Takeda Pharmaceutical?

Yes, BlackRock owns 0.09% of Takeda Pharmaceutical, totaling 1.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 18.59M$. In the last quarter, BlackRock decreased its holdings by -558K shares, a -27.99% change.

Who is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Managed asset portfolios is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 3.99% of its assets in 1.8M Takeda Pharmaceutical shares, valued at 33.31M$.

Who is the top mutual fund holder of Takeda Pharmaceutical shares?

American Funds American Mutual A is the top mutual fund holder of Takeda Pharmaceutical shares, with 0.57% of its total shares outstanding invested in 18.16M Takeda Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools